Eaton Vance Enhanced Equity Income Fund II is a US-based company operating in industry. The company is headquartered in Boston, Massachusetts. The company went IPO on 2005-01-27. Eaton Vance Enhanced Equity Income Fund II (the Fund) is a diversified, closed-end management investment company. The Fund’s primary investment objective is to provide current income, with a secondary objective of capital appreciation. The Fund generally invests in common stocks, which are exchange-traded call options. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. The Fund invests primarily in common stocks of U.S. issuers, although the Fund may invest up to 25% of its total assets in securities of foreign issuers, including American depositary receipts (ADRs), global depositary receipts (GDRs) and European depositary receipts (EDRs). Under normal market conditions, the Fund pursues its primary investment objective principally by employing an options strategy of writing (selling) covered call options on a substantial portion of its portfolio securities. The investment adviser of the Fund is Eaton Vance Management.
Eaton Vance Enhanced Equity Income Fund IIの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、Eaton Vance Enhanced Equity Income Fund IIの総資産は$1,225で、純利益は$277です。
EOSの主要な財務比率は何ですか?
Eaton Vance Enhanced Equity Income Fund IIの流動比率は306.25、純利益率は4,616.66、1株当たり売上高は$0.11です。
Eaton Vance Enhanced Equity Income Fund IIの収益はセグメントまたは地域別にどのように分けられていますか?
Eaton Vance Enhanced Equity Income Fund II の最大収益セグメントは Microbiome Therapeutics で、最新の利益発表における収益は 126,325,000 です。地域別に見ると、United States が Eaton Vance Enhanced Equity Income Fund II の主要市場であり、収益は 126,325,000 です。
Eaton Vance Enhanced Equity Income Fund IIは収益を上げていますか?
はい、最新の財務諸表によると、Eaton Vance Enhanced Equity Income Fund IIの純利益は$277です。
Eaton Vance Enhanced Equity Income Fund IIに負債はありますか?
はい、Eaton Vance Enhanced Equity Income Fund IIの負債は4です。
Eaton Vance Enhanced Equity Income Fund IIの発行済株式数は何株ですか?
Eaton Vance Enhanced Equity Income Fund IIの総発行済株式数は52株です。